Correlation Between PepGen and Acrivon Therapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PepGen and Acrivon Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PepGen and Acrivon Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PepGen and Acrivon Therapeutics, Common, you can compare the effects of market volatilities on PepGen and Acrivon Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PepGen with a short position of Acrivon Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of PepGen and Acrivon Therapeutics,.

Diversification Opportunities for PepGen and Acrivon Therapeutics,

PepGenAcrivonDiversified AwayPepGenAcrivonDiversified Away100%
0.78
  Correlation Coefficient

Poor diversification

The 3 months correlation between PepGen and Acrivon is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding PepGen and Acrivon Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acrivon Therapeutics, and PepGen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PepGen are associated (or correlated) with Acrivon Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acrivon Therapeutics, has no effect on the direction of PepGen i.e., PepGen and Acrivon Therapeutics, go up and down completely randomly.

Pair Corralation between PepGen and Acrivon Therapeutics,

Given the investment horizon of 90 days PepGen is expected to generate 3.12 times more return on investment than Acrivon Therapeutics,. However, PepGen is 3.12 times more volatile than Acrivon Therapeutics, Common. It trades about 0.14 of its potential returns per unit of risk. Acrivon Therapeutics, Common is currently generating about 0.01 per unit of risk. If you would invest  184.00  in PepGen on November 30, 2024 and sell it today you would earn a total of  59.00  from holding PepGen or generate 32.07% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

PepGen  vs.  Acrivon Therapeutics, Common

 Performance 
JavaScript chart by amCharts 3.21.15Dec2025Feb -80-60-40-2002040
JavaScript chart by amCharts 3.21.15PEPG ACRV
       Timeline  
PepGen 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days PepGen has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
JavaScript chart by amCharts 3.21.15DecJanFebJanFeb23456
Acrivon Therapeutics, 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Acrivon Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in March 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
JavaScript chart by amCharts 3.21.15DecJanFebJanFeb55.566.577.58

PepGen and Acrivon Therapeutics, Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-21.3-15.95-10.6-5.26-0.08915.110.3715.6420.9126.18 0.0040.0060.0080.0100.012
JavaScript chart by amCharts 3.21.15PEPG ACRV
       Returns  

Pair Trading with PepGen and Acrivon Therapeutics,

The main advantage of trading using opposite PepGen and Acrivon Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PepGen position performs unexpectedly, Acrivon Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acrivon Therapeutics, will offset losses from the drop in Acrivon Therapeutics,'s long position.
The idea behind PepGen and Acrivon Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios